17–20 May 2015
La Biodola, Isola d'Elba
Europe/Rome timezone

Initial in Vitro and in Vivo Assessment of Au@DTDTPA-RGD Nanoparticles for Gd-MRI and 68Ga-PET Dual Modality Imaging

20 May 2015, 11:00
1h 30m
Room Maria Luisa

Room Maria Luisa

Poster 8 - Bimodal MR-PET tracers Session 11 - Poster Session II

Speaker

Penelope Bouziotis (National Center for Scientific Research "Demokritos")

Description

Aim Gadolinium chelate coated gold nanoparticles (Au@DTDTPA) can be applied as contrast agents for both in vivo X-ray and magnetic resonance imaging. In this work, our aim was to radiolabel and evaluate this gold nanoparticle with Ga-68, in order to produce a dual modality PET/MRI imaging probe. Materials and Methods For a typical preparation of 68Ga-labeled nanoparticles, the Au@DTDTPA nanoparticles (Au@DTDTPA/Au@DTDTPA-RGD) were mixed with ammonium acetate buffer, pH 5 and 40 MBq of 68Ga eluate. The mixture was then incubated for 45 min at 65 °C. Radiochemical purity was determined by ITLC. In vitro stability of both radiolabeled species was assessed in saline and serum. In vitro cell binding experiments were performed on integrin ανβ3 receptor-positive U87MG cancer cells. Non-specific Au@DTDTPA was used for comparison. Ex vivo biodistribution studies and in vivo PET and MRI imaging studies in U87MG tumor-bearing SCID mice followed. Results The Au@DTDTPA nanoparticles were labeled with Gallium-68 at high radiochemical yield (>95%) and were stable at RT, and in the presence of serum, for up to 3 h. The cell binding assay on U87MG glioma cells proved that 68Ga-cRGD-Au@DTDTPA had specific recognition for these cells. Biodistribution studies in U87MG tumor-bearing SCID mice showed that the tumor to muscle ratio increased from 1 to 2 h p.i. (3,71 ± 0.22 and 4,69 ± 0.09 respectively), showing a clear differentiation between the affected and the non-affected tissue. The acquired PET and MRI images were in accordance to the ex vivo biodistribution results. Conclusion The preliminary results of this study warrant the need for further development of Au@DTDTPA nanoparticles radiolabeled with Ga-68, as possible dual-modality PET/MRI imaging agents.

Primary author

Dr Charalampos Tsoukalas (National Center for Scientific Research "Demokritos")

Co-authors

Dr Constantinos Anagnostopoulos (Biomedical Research Foundation, Academy of Athens) Dr Dimitris Stellas (Biomedical Research Foundation, Academy of Athens) Dr Gautier Laurent (Université de Franche-Comté, Institut UTINAM) Dr Gloria Jiménez Sánchez (Université de Franche-Comté, Institut UTINAM) Dr Lia Moulopoulos (Department of Radiology, Areteion Hospital, University of Athens Medical School) Dr Maria Paravatou-Petsotas (National Center for Scientific Research "Demokritos") Penelope Bouziotis (National Center for Scientific Research "Demokritos") Dr Rana Bazzi (Université de Franche-Comté, Institut UTINAM) Mr Stavros Xanthopoulos (National Center for Scientific Research "Demokritos") Dr Stephane Roux (Université de Franche-Comté, Institut UTINAM) Dr Theodoros Tsotakos (National Center for Scientific Research "Demokritos") Dr Vassilis Koutoulidis (Department of Radiology, Areteion Hospital, University of Athens Medical School)

Presentation materials

There are no materials yet.